Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Hess

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
Human CD4+ T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gammaStephen D Hess, Nejat K Egilmez, Nicola Bailey, et al.
The Journal of Investigative Dermatology|August 24, 2007
IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndromeJessica S Yoon, Sarah M Newton, Maria Wysocka, et al.
Iscience|December 17, 2024
Identification and development of TRPM4 antagonists to counteract neuronal excitotoxicityLars Binkle-Ladisch, Andy Pironet, Andrea Zaliani, et al.
Scientific Reports|October 7, 2021
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibersAdam J Davenport, Ioana Neagoe, Nico Bräuer, et al.
Assay and Drug Development Technologies|May 13, 2008
Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approachDavid R Piper, Steve R Duff, Hildegard C Eliason, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
Human CD4+ T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gammaStephen D Hess, Nejat K Egilmez, Nicola Bailey, et al.
The Journal of Investigative Dermatology|August 24, 2007
IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndromeJessica S Yoon, Sarah M Newton, Maria Wysocka, et al.
Iscience|December 17, 2024
Identification and development of TRPM4 antagonists to counteract neuronal excitotoxicityLars Binkle-Ladisch, Andy Pironet, Andrea Zaliani, et al.
Scientific Reports|October 7, 2021
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibersAdam J Davenport, Ioana Neagoe, Nico Bräuer, et al.
Assay and Drug Development Technologies|May 13, 2008
Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approachDavid R Piper, Steve R Duff, Hildegard C Eliason, et al.
Pageof 2